Literature DB >> 26853136

Abnormal response of distal Schwann cells to denervation in a mouse model of motor neuron disease.

Dario I Carrasco1, Ben A Bahr2, Kevin L Seburn3, Martin J Pinter4.   

Abstract

In several animal models of motor neuron disease, degeneration begins in the periphery. Clarifying the possible role of Schwann cells remains a priority. We recently showed that terminal Schwann cells (TSCs) exhibit abnormalities in postnatal mice that express mutations of the SOD1 enzyme found in inherited human motor neuron disease. TSC abnormalities appeared before disease-related denervation commenced and the extent of TSC abnormality at P30 correlated with the extent of subsequent denervation. Denervated neuromuscular junctions (NMJs) were also observed that lacked any labeling for TSCs. This suggested that SOD1 TSCs may respond differently than wildtype TSCs to denervation which remain at denervated NMJs for several months. In the present study, the response of SOD1 TSCs to experimental denervation was examined. At P30 and P60, SC-specific S100 labeling was quickly lost from SOD1 NMJs and from preterminal regions. Evidence indicates that this loss eventually becomes complete at most SOD1 NMJs before reinnervation occurs. The loss of labeling was not specific for S100 and did not depend on loss of activity. Although some post-denervation labeling loss occurred at wildtype NMJs, this loss was never complete. Soon after denervation, large cells appeared near SOD1 NMJ bands which colabeled for SC markers as well as for activated caspase-3 suggesting that distal SOD1 SCs may experience cell death following denervation. Denervated SOD1 NMJs viewed 7 days after denervation with the electron microscope confirmed the absence of TSCs overlying endplates. These observations demonstrate that SOD1 TSCs and distal SCs respond abnormally to denervation. This behavior can be expected to hinder reinnervation and raises further questions concerning the ability of SOD1 TSCs to support normal functioning of motor terminals.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Denervation cell death; Motor neuron disease; Motor terminal; Neurodegeneration; Schwann cell

Mesh:

Substances:

Year:  2016        PMID: 26853136      PMCID: PMC4788963          DOI: 10.1016/j.expneurol.2016.02.002

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  47 in total

Review 1.  Myelin phagocytosis by macrophages and nonmacrophages during Wallerian degeneration.

Authors:  Kazuho Hirata; Masaru Kawabuchi
Journal:  Microsc Res Tech       Date:  2002-06-15       Impact factor: 2.769

Review 2.  Roles of glial cells in the formation, function, and maintenance of the neuromuscular junction.

Authors:  Samir Koirala; Linga V Reddy; Chien-Ping Ko
Journal:  J Neurocytol       Date:  2003 Jun-Sep

3.  Insulin-like growth factor-I prevents caspase-mediated apoptosis in Schwann cells.

Authors:  C L Delaney; H L Cheng; E L Feldman
Journal:  J Neurobiol       Date:  1999-12

4.  Motor axon regeneration and muscle reinnervation in young adult and aged animals.

Authors:  Hyuno Kang; Jeff W Lichtman
Journal:  J Neurosci       Date:  2013-12-11       Impact factor: 6.167

5.  Glial cells decipher synaptic competition at the mammalian neuromuscular junction.

Authors:  Houssam Darabid; Danielle Arbour; Richard Robitaille
Journal:  J Neurosci       Date:  2013-01-23       Impact factor: 6.167

6.  Functional motor unit failure precedes neuromuscular degeneration in canine motor neuron disease.

Authors:  R J Balice-Gordon; D B Smith; J Goldman; L C Cork; A Shirley; T C Cope; M J Pinter
Journal:  Ann Neurol       Date:  2000-05       Impact factor: 10.422

7.  Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases.

Authors:  D Frey; C Schneider; L Xu; J Borg; W Spooren; P Caroni
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

Review 8.  Protective and pathogenic functions of macrophage subsets.

Authors:  Peter J Murray; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2011-10-14       Impact factor: 53.106

9.  Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

Authors:  Lindsey R Fischer; Deborah G Culver; Philip Tennant; Albert A Davis; Minsheng Wang; Amilcar Castellano-Sanchez; Jaffar Khan; Meraida A Polak; Jonathan D Glass
Journal:  Exp Neurol       Date:  2004-02       Impact factor: 5.330

Review 10.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

View more
  12 in total

Review 1.  New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction.

Authors:  Danielle Arbour; Christine Vande Velde; Richard Robitaille
Journal:  J Physiol       Date:  2016-12-01       Impact factor: 5.182

Review 2.  Clinical relevance of terminal Schwann cells: An overlooked component of the neuromuscular junction.

Authors:  Katherine B Santosa; Alexandra M Keane; Albina Jablonka-Shariff; Bianca Vannucci; Alison K Snyder-Warwick
Journal:  J Neurosci Res       Date:  2018-03-13       Impact factor: 4.164

3.  Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the SOD1G37R ALS Mouse Model.

Authors:  Éric Martineau; Danielle Arbour; Joanne Vallée; Richard Robitaille
Journal:  J Neurosci       Date:  2020-08-28       Impact factor: 6.167

Review 4.  Decoding the relationship between ageing and amyotrophic lateral sclerosis: a cellular perspective.

Authors:  Virenkumar A Pandya; Rickie Patani
Journal:  Brain       Date:  2020-04-01       Impact factor: 13.501

Review 5.  Terminal Schwann Cell Aging: Implications for Age-Associated Neuromuscular Dysfunction.

Authors:  Sandra Fuertes-Alvarez; Ander Izeta
Journal:  Aging Dis       Date:  2021-04-01       Impact factor: 6.745

6.  Motor function recovery: deciphering a regenerative niche at the neuromuscular synapse.

Authors:  Diego Zelada; Francisca Bermedo-García; Nicolás Collao; Juan P Henríquez
Journal:  Biol Rev Camb Philos Soc       Date:  2020-12-17

Review 7.  Heterogeneity and Potency of Peripheral Glial Cells in Embryonic Development and Adults.

Authors:  Artem Sinegubov; Daria Andreeva; Nikita Burzak; Maria Vasyutina; Lada Murashova; Vyacheslav Dyachuk
Journal:  Front Mol Neurosci       Date:  2022-03-25       Impact factor: 5.639

8.  Functional adaptation of glial cells at neuromuscular junctions in response to injury.

Authors:  Anna P Perez-Gonzalez; Frédéric Provost; Isabelle Rousse; Roberta Piovesana; Ouafa Benzina; Houssam Darabid; Benoit Lamoureux; Yu Shi Wang; Danielle Arbour; Richard Robitaille
Journal:  Glia       Date:  2022-04-27       Impact factor: 8.073

Review 9.  Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis.

Authors:  Valentina Cappello; Maura Francolini
Journal:  Int J Mol Sci       Date:  2017-10-03       Impact factor: 5.923

Review 10.  Temporospatial Analysis and New Players in the Immunology of Amyotrophic Lateral Sclerosis.

Authors:  Abhirami K Iyer; Kathryn J Jones; Virginia M Sanders; Chandler L Walker
Journal:  Int J Mol Sci       Date:  2018-02-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.